Delivery Order W9114F19D0007-W9114F19F0095
Award Date 10/1/19
Potential Completion Date 9/30/20
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Linde GMBH has been awarded a firm fixed price delivery order valued at $45,196.66 by the Defense Health Agency to supply nitric oxide, inomax at 800ppm. This order is being issued against an existing indefinite delivery contract between Linde GMBH and the Defense Health Agency for the provision of medical gases with a potential value of $344,759 and a period of performance through September 2024. No set-aside designation was applied to this order. The delivery order has a completion date of...
- The Defense Health Agency issued a delivery order to INO Therapeutics LLC on October 1, 2025, for nitric oxide medical gas with delivery system, with a ceiling value of $45,874.50 under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB). Place of performance is Hampton, NJ. The order is firm fixed price with an ultimate completion date of September 30, 2026. INO Therapeutics specializes in supplying INOMAX nitric oxide gas and inhalation therapy systems to federal healthcare agencies,...
- This is a firm fixed-price delivery order awarded by the U.S. Medical Command (MEDCOM) to INO Therapeutics LLC, a prime contractor that provides inhaled nitric oxide therapy systems and related medical gases to U.S. government agencies. The $148,092.00 contract is for the delivery of nitric oxide 800PPM gas to support healthcare programs at the San Antonio Military Medical Center (SAMMC). The award was made under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) without any...
- The Defense Health Agency issued a delivery order to INO Therapeutics LLC on October 1, 2025, with a ceiling value of $121,260 for inhaled nitric oxide therapeutic gases and supplies under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). Place of performance is Lewis-McChord, Washington. The order extends through September 30, 2030. INO Therapeutics supplies INOMAX nitric oxide gas, delivery equipment, and inhalation therapy services to federal healthcare facilities serving neonatal,...
- This federal contract award is for the delivery of aviator's breathing oxygen, technical nitrogen, and nitric oxide (Inomax 800ppm) to support military healthcare operations in Germany. The contract was awarded to Linde GMBH, a prominent international supplier of technical and medical gases headquartered in Germany. The contract, awarded by the Defense Health Agency, is a single-award indefinite delivery contract (IDV) with a ceiling value of $394,810.10 and a performance period from June 14,...
- This federal contract award, identified as W81K0015P0330, was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense. The $357,588.00 firm fixed-price purchase order is for the supply of 800 PPM nitric oxide gas to the San Antonio Military Medical Center. The prime contractor, INO Therapeutics LLC, is a company that specializes in providing inhaled nitric oxide therapy systems and related medical gases to government agencies, primarily the Department of Veterans Affairs and the...
- This firm fixed-price Delivery Order contract was awarded by the Department of the Army Medical Command to INO Therapeutics LLC, a foreign-owned for-profit company, to provide NITRIC OXIDE THERAPY. The contract has a potential value of $283,737.70 and a completion date of December 31, 2020. The contract was awarded on January 11, 2018 under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), without any set-aside designation. INO Therapeutics has been a prime contractor for over 50 federal...
- The Defense Health Agency awarded a delivery order valued at $602,910 to INO Therapeutics LLC for 3,500 hours of inhaled nitric oxide (INO) therapy services, with an ultimate completion date of January 9, 2024. This firm fixed-price delivery order, issued under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB), represents a modification to an existing option year contract and does not utilize a set-aside designation. The work will be performed in Hampton, New Jersey, supporting the...
- Veterans Integrated Service Network 15 issued a delivery order to INO Therapeutics LLC on July 7, 2024, for INOMAX inhaled nitric oxide with delivery system, with a ceiling value of $413,879.32 under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB). Place of performance is Hazelwood, MO. The order extends through July 6, 2029. INO Therapeutics supplies inhaled nitric oxide therapeutic gas, INOMAX cylinders with delivery systems, and inhalation therapy services to federal...
- <p>The Department of Energy issued a $2,784.24 delivery order to Linde GMBH on February 25, 2026, for technical nitrogen supply to support U.S. military healthcare operations. The order is placed against a Defense Health Agency single-award indefinite delivery contract valued at $394,810.10 and running through November 9, 2026.</p> <p>Place of performance is Germany. The order carries a firm fixed price and an ultimate completion date of March 6, 2026. No set-aside applies.</p>